Solventum to spin off Health Information Systems business; $1.4B revenue unit

Solventum Corp

Solventum intends to separate its Health Information Systems (HIS) business within 12-18 months.
HIS generated $1.4B in annual sales (FY2025), used by >75% of U.S. hospitals, processes 660M clinical documents/month.
Addressable market ~$10B growing 5-6% annually; HIS has AI-driven autonomous coding capabilities.
Separation aims to sharpen Solventum as a dedicated MedTech company focused on MedSurg and Dental Solutions.
Advisors: Morgan Stanley, Goldman Sachs; Cleary Gottlieb as legal counsel.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.